Dr. Leela Lavasani Joins JDRF’s South Gulf Coast Chapter Board

JDRF, the leading global organization funding type 1 diabetes (T1D) research, announces the appointment of Dr. Leela Lavasani as a new JDRF South Gulf Coast Chapter board member. Board members provide volunteer guidance to the chapter and the local T1D community, playing a vital role in executing fundraising, leadership and advocacy activities to benefit local families and the 1.25 million Americans who live with this autoimmune disease.

The South Gulf Coast JDRF Chapter was formed in 2000 and has sustained an impressive track record of patient education programs, support groups, public awareness and advocacy.

“We want to thank Dr. Lavasani for her dedication to supporting JDRF and are delighted to welcome her to the South Gulf Coast JDRF Chapter,” said Kathy Cleeland, Executive Director of JDRF’s South Gulf Coast Chapter. “We’re confident that Dr. Lavasani’s skills will provide the strengths needed to help advance JDRF’s goals of improving the lives of families and individuals living with type 1 diabetes as we strive to unlock the science for a cure.”

Dr.  Leela Lavasani is a board certified otolaryngologist, head and neck surgeon with Florida Gulf Coast Ear Nose and Throat.  Originally from Minnesota, she attended college at Macalester College.  She then went on to George Washington medical school in Washington DC.  Her residency training was completed at Thomas Jefferson University in Philadelphia.  She has now lived in Naples for over 5 years, with her husband and 3 daughters.  Her practice has a focus in head and neck cancer patients, but practices general ENT as well.  She enjoys being in active member in her community.

T1D can strike both children and adults at any age. About 40,000 people are diagnosed each year in the U.S. It comes on suddenly, causes dependence on injected or pumped insulin for life, and carries the constant threat of devastating complications such as kidney, nerve or eye disease. JDRF is committed to advancing life-changing breakthroughs from development to the marketplace and into the hands of people with T1D.

###

About T1D
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.

 

About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF or call 239-591-2825.